SL SNOTRA LABORATORIES
DEAD

Serial Number

86836612

Owner

SNOTRA LABORATORIES, INC.

Attorney

Susan M. Mulholland

Filing Date

Dec 2, 2015

Add to watchlist:

No watchlists yet
View on USPTO

SL SNOTRA LABORATORIES Trademark

Serial Number: 86836612

SL SNOTRA LABORATORIES is a trademark filed by SNOTRA LABORATORIES, INC. on December 2, 2015. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

SNOTRA LABORATORIES, INC.

6 Henry Street
Saugus, MA 01906

Entity Type: 03

Trademark Details

Filing Date

December 2, 2015

Registration Date

Not Registered

Published for Opposition

November 1, 2016

Goods & Services

Project management services for others for business purposes in the field of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; providing project management services for others for business purposes related to the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business consultation in the field of healthcare, namely, providing independent consultative review of clinical trials, peri-approval studies, post-approval studies, observational studies, post-approval surveys and clinical patient registries, post-approval marketing studies, quality improvement, and patient support programs in the healthcare, biopharmaceutical, and medical device and diagnostic industries all excluding the provision of medical services and medical treatment services

Medical services in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices. Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, evaluating disease management and treatment protocols and patient outcome analysis services

Scientific research and development; conducting research and development services in the field of pharmaceuticals and medical devices; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; conducting clinical trials of pharmaceuticals and medical devices; scientific research services, namely, tracking, analyzing, forecasting, and reporting data in the field of clinical trials of pharmaceuticals and medical devices; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others; medical and scientific research in the nature of conducting peri-approval studies and post-approval studies evaluating the safety, effectiveness, value, risk, and quality of healthcare products, therapies an medical services; providing information relating to the development and validation of drugs, pharmaceutical products, medical products, medical devices and biologics; medical and scientific research featuring peri-approval studies and post-approval studies for evaluating the safety, effectiveness, value, risk, and quality of healthcare products, therapies, and medical services

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 29, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 29, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2017 EXRA
SOU EXTENSION 1 GRANTED
Jun 22, 2017 EX1G
SOU EXTENSION 1 FILED
Jun 22, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 22, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2016 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2016 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 9, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2015 NWOS
NEW APPLICATION ENTERED
Dec 5, 2015 NWAP